Epidermal Growth Factor Receptor Protein Expression and Gene Amplification in Normal, Hyperplastic, and Cancerous Glottic Tissue: Immunohistochemical and Fluorescent in Situ Hybridization Study on Tissue Microarrays

被引:22
作者
Braut, Tamara [1 ]
Krstulja, Mira [2 ]
Kujundzic, Milodar [1 ]
Manestar, Dubravko [1 ]
Hadzisejdic, Ita [2 ]
Jonjic, Nives [2 ]
Grahovac, Blazenka [2 ]
Manestar, Darko [1 ]
机构
[1] Clin Hosp Ctr Rijeka, Dept Otorhinolaryngol Head & Neck Surg, Rijeka 51000, Croatia
[2] Univ Rijeka, Sch Med, Dept Pathol, Rijeka, Croatia
关键词
SQUAMOUS-CELL CARCINOMA; COPY NUMBER; LARYNGEAL LESIONS; KINASE INHIBITORS; COLORECTAL-CANCER; EGFR GENE; HEAD; NECK; MUTATIONS; OVEREXPRESSION;
D O I
10.3325/cmj.2009.50.370
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aim To evaluate the importance of epidermal growth factor receptor (EGFR) protein overexpression and gene amplification in carcinogenesis of glottic cancer. Method In order to evaluate EGFR expression at protein and gene level, immunohistochemical (IHC) analysis and fluorescent in situ hybridization (FISH) were performed on tissue microarrays of laryngeal tissue (145 samples)-38 samples of normal mucosa, 46 samples of hyperplastic lesions, and 61 samples of cancerous lesions. Results Membranous (mEGFR) and cytoplasmic (cEGFR) EGFR expression was significantly different between the analyzed groups. The differences were most striking in the suprabasal-transforming zone. IHC evaluation showed that high and low mEGFR staining contributed to the differentiation of dysplastic lesions, simple hyperplasia, and cancerous tissue, as well as between different degrees of atypia in hyperplastic lesions (P < 0.050). EGFR gene amplification was not found in simple and abnormal hyperplastic lesions, but it was confirmed in 2/21 atypical hyperplasias, indicating that gene amplification can facilitate identification of malignant potential in hyperplastic lesions. In cancerous tissue, EGFR gene amplification was found in 8/50 samples. EGFR gene amplification was found in preinvasive cancer in one patient. In invasive carcinomas, gene amplification was not associated with stage or grade. Carcinomas with gene amplification showed significantly higher cEGFR expression (basal layer P = 0.003; suprabasal layer P = 0.002). Conclusions This study confirmed an increase in EGFR protein expression and gene amplification with the increase in biological aggressiveness of glottic lesions. A correlation between EGFR gene amplification and protein expression was established. Gene amplification proved to be an early event in glottic carcinogenesis, indicating its importance for glottic cancer prevention, early detection, and protocol selection.
引用
收藏
页码:370 / 379
页数:10
相关论文
共 36 条
[1]
[Anonymous], CLIN CANC RES
[2]
Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors [J].
Bonomi, Philip D. ;
Buckingham, Lela ;
Coon, John .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4606S-4612S
[3]
Validation of tissue array technology in head and neck squamous cell carcinoma [J].
Chen, B ;
van den Brekel, MWM ;
Buschers, W ;
Balm, AJM ;
van Velthuysen, MLF .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (11) :922-930
[4]
Standardization of HER2 testing:: results of an international proficiency-testing ring study [J].
Dowsett, Mitch ;
Hanna, Wedad M. ;
Kockx, Mark ;
Penault-Llorca, Frederique ;
Rueschoff, Josef ;
Gutjahr, Thorsten ;
Habben, Kai ;
van de Vijver, Marc J. .
MODERN PATHOLOGY, 2007, 20 (05) :584-591
[5]
Freier K, 2003, CANCER RES, V63, P1179
[6]
Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions [J].
Gale, N ;
Kambic, V ;
Poljak, M ;
Cör, A ;
Velkavrh, D ;
Mlacak, B .
ONCOLOGY, 2000, 58 (02) :117-125
[7]
Hellquist H, 1999, HISTOPATHOLOGY, V34, P226
[8]
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest Oncology Group Study [J].
Hirsch, FR ;
Varella-Garcia, M ;
McCoy, J ;
West, H ;
Xavier, AC ;
Gumerlock, P ;
Bunn, PA ;
Franklin, WA ;
Crowley, J ;
Gandara, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6838-6845
[9]
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number [J].
Italiano, Antoine ;
Follana, Philippe ;
Caroli, Francois-Xavier ;
Badetti, Jean-Luc ;
Benchimol, Daniel ;
Garnier, Georges ;
Gugenheim, Jean ;
Haudebourg, Juliette ;
Keslair, Frederique ;
Lesbats, Gerard ;
Lledo, Gerard ;
Roussel, Jean-Francois ;
Pedeutour, Florence ;
Francois, Eric .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) :649-654
[10]
Cancer Statistics, 2009 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2009, 59 (04) :225-249